LEANFA Srl
Desconocido
TABLA: Development and Commercialisation of Transbronchial Lung Ablation to Treat Lung Cancer
LEANFA SRL
participó en un
H2020:
H2020-EIC-FTI-2018-2020
Lung cancer is the most common cause of cancer deaths in the EU and worldwide with more than 0.4M people diagnosed
each year. It has a disma...
2020-03-26 - 2023-05-31 | Financiado
2020-03-26 - 2023-05-31 | Financiado
* No se disponen de datos de la empresa actual.